Clinical Pathways
Hypertrophic Cardiomyopathy — Paediatric
An echo-first, eligibility-gated HCM Risk-Kids 5-year sudden cardiac death risk estimate for eligible children.
Governed risk model
HCM Risk-Kids
Enter the variables required by the internally validated paediatric model. HCM Risk-Kids has subsequently undergone external validation in an independent, geographically diverse multicentre cohort of 421 children. The result supports clinical risk assessment and shared decision-making; it does not replace specialist judgment or determine ICD implantation.